Also trades as: 6849.T (JPX) · $vol 7M · NHNKY (OTC) · $vol 0M

$9.80

+0.00 (+0.00%)

OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 53 · $1.6B mcap · 131M float · 0.0015% daily turnover · Short 90% of daily vol

Revenue

$236.6B +4.9% ▲

5Y CAGR: +3.4%

Gross Profit

$118.7B +1.3% ▲

5Y CAGR: +3.0%

Operating Income

$18.9B -8.7% ▼

5Y CAGR: -6.9%

Net Income

$14.6B +3.6% ▲

5Y CAGR: -4.4%

EPS (Diluted)

$89.48 +5.4% ▲

5Y CAGR: -16.0%

EBITDA

$24.8B -4.4% ▼

5Y CAGR: -4.2%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$205.1B	$206.6B	$222.0B	$225.4B	$236.6B
YoY Growth	+2.7%	+0.7%	+7.4%	+1.5%	+4.9%
Cost of Revenue	$96.0B	$100.7B	$110.6B	$108.3B	$117.8B
Gross Profit	$109.1B	$105.9B	$111.3B	$117.2B	$118.7B
Gross Margin	53.2%	51.3%	50.2%	52.0%	50.2%
R&D Expenses	$5.7B	$6.2B	$7.0B	$0	$7.5B
SG&A Expenses	$70.0B	$75.9B	$82.0B	$86.8B	$92.3B
Operating Expenses	$78.1B	$84.8B	$91.8B	$96.4B	$99.8B
Operating Income	$31.0B	$21.1B	$19.6B	$20.7B	$18.9B
Operating Margin	15.1%	10.2%	8.8%	9.2%	8.0%
Interest Expense	$11M	$10M	$24M	$144M	$343M
Income Before Tax	$34.3B	$24.7B	$29.4B	$21.6B	$20.1B
Tax Expense	$10.8B	$7.6B	$12.3B	$7.5B	$5.4B
Net Income	$23.4B	$17.1B	$17.0B	$14.1B	$14.6B
Net Margin	11.4%	8.3%	7.7%	6.3%	6.2%
EPS (Diluted)	$276.50	$203.28	$101.23	$84.88	$89.48
EBITDA	$38.1B	$28.5B	$33.2B	$25.9B	$24.8B
Shares Outstanding	85M	84M	168M	166M	163M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$46.2B	$56.6B	$55.7B	$66.9B	$50.0B	$58.9B	$55.9B	$71.5B
Cost of Revenue	$24.4B	$26.5B	$25.2B	$32.2B	$23.7B	$28.0B	$27.6B	$36.3B
Gross Profit	$21.9B	$30.1B	$30.5B	$34.7B	$26.3B	$30.9B	$28.3B	$35.2B
Gross Margin	47.3%	53.1%	54.8%	51.9%	52.6%	52.5%	50.6%	49.2%
R&D Expenses	$0	$0	$0	$6.8B	$11M	$1.8B	$1.9B	$2.2B
SG&A Expenses	$23.1B	$23.7B	$24.7B	$15.3B	$24.9B	$25.5B	$25.9B	$25.0B
Operating Expenses	$23.1B	$23.7B	$24.7B	$24.9B	$24.9B	$25.5B	$25.9B	$27.2B
Operating Income	-$1.2B	$6.4B	$5.8B	$9.8B	$1.4B	$5.4B	$2.4B	$8.0B
Operating Margin	-2.7%	11.2%	10.5%	14.6%	2.8%	9.2%	4.3%	11.2%
Interest Expense	$0	$0	$0	$620K	$742K	$40M	$83M	$113M
Income Before Tax	$1.7B	$240M	$11.4B	$8.3B	$471M	$6.3B	$3.2B	$10.1B
Tax Expense	$902M	$543M	$3.7B	$2.3B	$278M	$1.9B	$1.3B	$2.0B
Net Income	$766M	-$303M	$7.7B	$6.0B	$137M	$4.5B	$1.9B	$8.2B
Net Margin	1.7%	-0.5%	13.8%	8.9%	0.3%	7.6%	3.4%	11.4%
EPS (Diluted)	$4.57	$-1.81	$46.36	$36.38	$0.84	$27.28	$11.58	$49.53
EBITDA	-$315M	$7.4B	$6.9B	$11.0B	$2.5B	$8.0B	$4.7B	$9.7B
Shares Outstanding	168M	167M	166M	164M	163M	163M	163M	162M

NHNKF OTC